SARS-CoV-2

Tingting Li1, Bingjie Zhou2, Haoyu Dong3

  • 1Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200030, China.

Advanced biotechnology
|January 30, 2025
PubMed
概括

一种新的人类单克隆抗体FD20有效中和了SARS-CoV-2的Omicron变种. 这种抗体显示出作为COVID-19的治疗选择的希望,即使对未来的变种也是如此.